Segment Information

6 Months Ended

Jun. 30, 2020

We operate under two reportable segments: Healthcare and Research. The Healthcare segment is focused on remote cardiac monitoring to identify cardiac arrhythmias or heart rhythm disorders and to monitor the functionality of implantable cardiac devices. We offer cardiologists, electrophysiologists, neurologists and primary care physicians a full spectrum of solutions, which provides them with a single source of remote cardiac monitoring services. These services include MCT, event, traditional Holter, extended Holter, Pacemaker, International Normalized Ratio and Implantable Loop Recorder and other implantable cardiac device monitoring. The Research segment is engaged in centralized core laboratory services providing cardiac monitoring, imaging services, scientific consulting and data management services for drug and medical device trials. Included in the Corporate and Other category is the manufacturing, testing and marketing of cardiac and blood glucose monitoring devices to medical companies, clinics and hospitals and corporate overhead and other items not allocated to any of our reportable segments.

Expenses that can be specifically identified with a segment have been included as deductions in determining pre-tax segment income/(loss). Any remaining expenses including integration and other charges, as well as the elimination of costs associated with intercompany revenue, are included in Corporate and Other. Also included in Corporate and Other is our net interest expense and other financing expenses. We do not allocate assets to the individual segments.



	Three Months Ended June 30, 2020
	Reporting Segment				Corporate and Other
(in thousands)	Healthcare		Research		Corporate and Other			Consolidated
Total revenue	$	84,382	$	11,459	$	3,268		$	99,109
Gross profit	56,341		4,426		760			61,527
Income/(loss) before income taxes	26,005		919		(23,987		)	2,937
Depreciation and amortization	8,962		923		994			10,879
Capital expenditures	8,692		395		1,039			10,126



	Three Months Ended June 30, 2019
	Reporting Segment				Corporate and Other
(in thousands)	Healthcare		Research		Corporate and Other			Consolidated
Total revenue	$	95,004	$	13,879	$	2,920		$	111,803
Gross profit	64,387		5,335		518			70,240
Income/(loss) before income taxes	32,514		1,052		(20,459		)	13,107
Depreciation and amortization	8,327		1,004		861			10,192
Capital expenditures	9,080		1,306		372			10,758



	Six Months Ended June 30, 2020
	Reporting Segment				Corporate and Other
(in thousands)	Healthcare		Research		Corporate and Other			Consolidated
Total revenue	$	180,089	$	25,279	$	6,772		$	212,140
Gross profit	120,765		10,101		1,169			132,035
Income/(loss) before income taxes	55,881		2,962		(43,573		)	15,270
Depreciation and amortization	17,397		1,989		1,978			21,364
Capital expenditures	14,903		786		1,421			17,110



	Six Months Ended June 30, 2019
	Reporting Segment				Corporate and Other
(in thousands)	Healthcare		Research		Corporate and Other			Consolidated
Total revenue	$	183,013	$	26,843	$	5,926		$	215,782
Gross profit	124,251		9,669		1,098			135,018
Income/(loss) before income taxes	62,122		1,816		(41,219		)	22,719
Depreciation and amortization	16,618		1,932		1,663			20,213
Capital expenditures	13,522		1,788		782			16,092